On ECHEMI
Home > Drugs > Dapagliflozin Registered Holders
Dapagliflozin structure

Dapagliflozin structure

Dapagliflozin

Dapagliflozin (BMS-512148) is a sodium-glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.

Find 83 Related Holders

MSN LABORATORIES PRIVATE LTD
United States United States

API Registration Country

API Active
ALIVUS LIFE SCIENCES LTD
United States United States

API Registration Country

API Active
ALEMBIC PHARMACEUTICALS LTD
United States United States

API Registration Country

API Active
APITORIA PHARMA PRIVATE LTD
United States United States

API Registration Country

API Active
Granules India Ltd
United States United States

API Registration Country

API Active
ZYDUS LIFESCIENCES LTD
United States United States

API Registration Country

API Active
Pharmaceutical Works Polpharma S.A.
Japan Japan

API Registration Country

API Active
BIOCON LTD
United Kingdom United Kingdom

API Registration Country

API Active
  • Founded in:

    2018-11-30 00:00:00
  • Country:

    United Kingdom United Kingdom
  • Address:

    Torton Grove Torton Lane, Torton, Kidderminster, Worcestershire, United Kingdom, DY11 7SG
KYONGBO PHARMACEUTICAL CO., LTD
South Korea South Korea

API Registration Country

API Active
  • Founded in:

    1987-03-31 00:00:00
  • Country:

    South Korea South Korea
  • Address:

    174
MSN LABORATORIES PRIVATE LIMITED
Brazil Brazil

API Registration Country

API Active
  • Country:

    Brazil Brazil
  • Address:

    MSN HOUSE, PLOT NO C- 24 SANATH NAGAR IE, EXTERIOR - EX
  • Email:

Recommended Suppliers of Dapagliflozin
View 146 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.